Gain Therapeutics GANX
NASDAQ GANX
$1.29 +0.10 (+8.40%)
At close: Oct 22, 2026 · 4:00 PM EDT

Gain Therapeutics (GANX) Change in Taxes (2020 - 2021)

Updated

Gain Therapeutics (GANX) recorded Change in Taxes of $3,456 in Q1 2021, compared with -$2,355 a year earlier.

Analysis

Gain Therapeutics (GANX) Change in Taxes (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Taxes (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -2.22 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 77.00 Mn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 171.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Gain Therapeutics 55.91 Mn -3.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 3,456.00
Mar 31, 2020 -2,355.00
API Access

Gain Therapeutics Change in Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-taxes&ticker=GANX&period=max&api_key=YOUR_API_KEY